Found: 10
Select item for more details and to access through your institution.
Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2873, doi. 10.1038/onc.2012.302
- By:
- Publication type:
- Article
Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2891, doi. 10.1038/onc.2012.300
- By:
- Publication type:
- Article
Annexin A6 is a scaffold for PKCα to promote EGFR inactivation.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2858, doi. 10.1038/onc.2012.303
- By:
- Publication type:
- Article
The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2805, doi. 10.1038/onc.2012.411
- By:
- Publication type:
- Article
HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2828, doi. 10.1038/onc.2013.32
- By:
- Publication type:
- Article
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2882, doi. 10.1038/onc.2012.297
- By:
- Publication type:
- Article
Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2836, doi. 10.1038/onc.2012.308
- By:
- Publication type:
- Article
Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2818, doi. 10.1038/onc.2012.304
- By:
- Publication type:
- Article
The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2900, doi. 10.1038/onc.2012.299
- By:
- Publication type:
- Article
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway.
- Published in:
- Oncogene, 2013, v. 32, n. 23, p. 2848, doi. 10.1038/onc.2012.306
- By:
- Publication type:
- Article